Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body ... doctors say more long-term data is needed before committing patients to this drug for ...

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.